Of note, hyperactive ERK signaling is known to be a indicator in the propagation of many forms of cancer.[21] Therefore, we hypothesized that RIPK3 could regulate ERK activation by a post‐transcriptional regulatory mechanism, thereby suppressing the excessive proliferation of DP thymocytes caused by abnormal ERK activation. The gene discussed is RIPK3; the disease is cancer.